Weight loss prevents urinary incontinence in women with type 2 diabetes: results from the Look AHEAD trial
- PMID: 22264468
- PMCID: PMC3646565
- DOI: 10.1016/j.juro.2011.10.139
Weight loss prevents urinary incontinence in women with type 2 diabetes: results from the Look AHEAD trial
Abstract
Purpose: We determined the effect of weight loss on the prevalence, incidence and resolution of weekly or more frequent urinary incontinence in overweight/obese women with type 2 diabetes after 1 year of intervention in the Look AHEAD (Action for Health in Diabetes) trial.
Materials and methods: Women in this substudy (2,739, mean ± SD age 57.9 ± 6.8 years, body mass index 36.5 ± 6.1 kg/m(2)) were randomized into an intensive lifestyle weight loss intervention or a diabetes support and education control condition.
Results: At baseline 27% of participants reported urinary incontinence on a validated questionnaire (no significant difference by intensive lifestyle intervention vs diabetes support and education). After 1 year of intervention the intensive lifestyle intervention group in this substudy lost 7.7 ± 7.0 vs 0.7 ± 5.0 kg in the diabetes support and education group. At 1 year fewer women in the intensive lifestyle intervention group reported urinary incontinence (25.3% vs 28.6% in the diabetes support and education group, p = 0.05). Among participants without urinary incontinence at baseline 10.5% of intensive lifestyle intervention and 14.0% of diabetes support and education participants experienced urinary incontinence after 1 year (p = 0.02). There were no significant group differences in the resolution of urinary incontinence (p >0.17). Each kg of weight lost was associated with a 3% reduction in the odds of urinary incontinence developing (p = 0.01), and weight losses of 5% to 10% reduced these odds by 47% (p = 0.002).
Conclusions: Moderate weight loss reduced the incidence but did not improve the resolution rates of urinary incontinence at 1 year among overweight/obese women with type 2 diabetes. Weight loss interventions should be considered for the prevention of urinary incontinence in overweight/obese women with diabetes.
Trial registration: ClinicalTrials.gov NCT00017953.
Copyright © 2012 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.
Figures
References
-
- Brown JS, Grady D, Ouslander JG, et al. Prevalence of urinary incontinence and associated risk factors in postmenopausal women. Heart & Estrogen/Progestin Replacement Study (HERS) Research Group. Obstet Gynecol. 1999 Jul;94:66. - PubMed
-
- Hannestad YS, Rortveit G, Daltveit AK, Hunskaar S. Are smoking and other lifestyle factors associated with female urinary incontinence? The Norwegian EPINCONT Study. BJOG. 2003 Mar;110:247. - PubMed
-
- Lifford KL, Curhan GC, Hu FB, et al. Type 2 diabetes mellitus and risk of developing urinary incontinence. J Am Geriatr Soc. 2005 Nov;53:1851. - PubMed
Publication types
MeSH terms
Associated data
Grants and funding
- U01 DK057151/DK/NIDDK NIH HHS/United States
- DK57151/DK/NIDDK NIH HHS/United States
- U01 DK057154/DK/NIDDK NIH HHS/United States
- U01 DK057171/DK/NIDDK NIH HHS/United States
- DK57182/DK/NIDDK NIH HHS/United States
- U01 DK057182/DK/NIDDK NIH HHS/United States
- U01 DK057002/DK/NIDDK NIH HHS/United States
- U01 DK057177/DK/NIDDK NIH HHS/United States
- M01 RR001066/RR/NCRR NIH HHS/United States
- U01 DK057078/DK/NIDDK NIH HHS/United States
- DK57008/DK/NIDDK NIH HHS/United States
- DK57135/DK/NIDDK NIH HHS/United States
- DK57078/DK/NIDDK NIH HHS/United States
- M01RR00211-40/RR/NCRR NIH HHS/United States
- P30 DK048520/DK/NIDDK NIH HHS/United States
- U01 DK057135/DK/NIDDK NIH HHS/United States
- P30 DK046204/DK/NIDDK NIH HHS/United States
- DK57171/DK/NIDDK NIH HHS/United States
- M01 RR002719/RR/NCRR NIH HHS/United States
- K24 DK080775/DK/NIDDK NIH HHS/United States
- DK57131/DK/NIDDK NIH HHS/United States
- M01 RR000056/RR/NCRR NIH HHS/United States
- U01 DK057219/DK/NIDDK NIH HHS/United States
- DK57149/DK/NIDDK NIH HHS/United States
- U01 DK056992/DK/NIDDK NIH HHS/United States
- M01 RR00051/RR/NCRR NIH HHS/United States
- DK57002/DK/NIDDK NIH HHS/United States
- M01 RR000056 44/RR/NCRR NIH HHS/United States
- M01-RR-02719/RR/NCRR NIH HHS/United States
- U01 DK057136/DK/NIDDK NIH HHS/United States
- DK57178/DK/NIDDK NIH HHS/United States
- M01 RR000211/RR/NCRR NIH HHS/United States
- P30 DK48520/DK/NIDDK NIH HHS/United States
- U01 DK057131/DK/NIDDK NIH HHS/United States
- M01 RR000051/RR/NCRR NIH HHS/United States
- DK57136/DK/NIDDK NIH HHS/United States
- PA-98-053/PHS HHS/United States
- DK57154/DK/NIDDK NIH HHS/United States
- DK57219/DK/NIDDK NIH HHS/United States
- DK57177/DK/NIDDK NIH HHS/United States
- U01 DK056990/DK/NIDDK NIH HHS/United States
- U01 DK057178/DK/NIDDK NIH HHS/United States
- U01 DK057008/DK/NIDDK NIH HHS/United States
- DK56990/DK/NIDDK NIH HHS/United States
- DK 046204/DK/NIDDK NIH HHS/United States
- M01-RR-01066/RR/NCRR NIH HHS/United States
- U01 DK057149/DK/NIDDK NIH HHS/United States
- DK56992/DK/NIDDK NIH HHS/United States
- P30 DK017047/DK/NIDDK NIH HHS/United States
